Brochure
6 Oct 2021

A Global Leader in Sterile Contract Manufacturing

PDF 1.4 MB

Our processes and systems are tailored to meet your parenteral manufacturing needs. We offer conventional sterile dosage forms, including prefilled syringes, liquid vials, lyophilized vials and cartridges as well as cost-saving diluents for reconstitution.

Content provided by our supplier

Baxter Healthcare Corporation

  • US
  • 2015
    On CPhI since
  • 2
    Certificates
  • 5000+
    Employees
Contract Service

Other Content from Baxter Healthcare Corporation

  • News Baxter BioPharma Solutions to manufacture Novavax COVID-19 vaccine

    Manufacturing at Baxter's Halle/Westfalen, Germany facility will help increase commercial production and promote access in UK and European markets
  • Brochure Complex Sterile Manufacturing: More Than 60 Years of Oncology Experience

    Parenteral manufacturing can be a complicated process. Cytotoxics, antibody-drug conjugates (ADCs), highly potent compounds, biologics and lyophilized products present many challenges and require specialized understanding and expertise.
  • Brochure Maximize Your Molecule's Full Potential

    We know the high-stakes challenges you face in today's complex parenteral marketplace - and how the work we do is vital to the patients you serve. That's why we work closely with you at every step to help you achieve your molecule's full potential and your commercialization objectives.
  • Whitepaper Seasonal Vaccine Manufacturing

    The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain selection. The limited-time span from strain selection to distribution requires most vaccine producers to rely on outsourcing partners to ensure timely production and supply. While the right facility and technical expertise are important, vaccine developers should also focus on securing a culture of speed and execution, shared expectations, and continuous improvement. This whitepaper from Baxter’s contract manufacturing business, BioPharma Solutions examines three key areas to evaluate when selecting an outsourcing partner for vaccines production to ensure quality and on-time delivery.